ACE2 is the indispensable entry receptor for SARS-CoV and SARS-CoV-2. Because of the COVID-19 pandemic, it has become one of the most therapeutically targeted human …
Vaccines | Free Full-Text | A Case Report: Multifocal Necrotizing Encephalitis and Myocarditis after BNT162b2 mRNA Vaccination against COVID-19 Next Article in Journal Cross-National …
Worldwide there have been over 760 million confirmed coronavirus disease 2019 (COVID- 19) cases, and over 13 billion COVID-19 vaccine doses have been administered as of April …
N Hanna, A Heffes-Doon, X Lin, CM De Mejia… - JAMA …, 2022 - jamanetwork.com
Results| Of 4216 trainees, 4121 (97.7%) responded. Respondents and nonrespondents were not significantly different in age, gender, medical school location (US or international) …
AJ Krauson, FVC Casimero, Z Siddiquee, JR Stone - npj Vaccines, 2023 - nature.com
At the start of the COVID-19 pandemic, the BNT162b2 (BioNTech-Pfizer) and mRNA-1273 (Moderna) mRNA vaccines were expediently designed and mass produced. Both vaccines …
PI Parry, A Lefringhausen, C Turni, CJ Neil, R Cosford… - Biomedicines, 2023 - mdpi.com
The COVID-19 pandemic caused much illness, many deaths, and profound disruption to society. The production of 'safe and effective'vaccines was a key public health target. Sadly …
Abstract Recently, The Lancet published a study on the effectiveness of COVID-19 vaccines and the waning of immunity with time. The study showed that immune function among …
S Seneff, G Nigh, AM Kyriakopoulos… - Food and Chemical …, 2022 - Elsevier
Abstract The mRNA SARS-CoV-2 vaccines were brought to market in response to the public health crises of Covid-19. The utilization of mRNA vaccines in the context of infectious …
TE Fertig, L Chitoiu, DS Marta, VS Ionescu… - Biomedicines, 2022 - mdpi.com
COVID-19 mRNA vaccines effectively reduce incidence of severe disease, hospitalisation and death. The biodistribution and pharmacokinetics of the mRNA-containing lipid …